Stem Cell Transplant Myeloma Prognosis

Five year survival for multiple myeloma patients given asct has grown from 47 in 1997 or earlier to 70 in those treated in 2014 or later a study found.

Stem cell transplant myeloma prognosis.

All things considered while the autologous transplant can make the myeloma go away for a period of time even years it does not cure the growth and inevitably the myeloma back. Outcomes for older patients and those with low risk disease improved but those with high risk disease still experience poor survival. Autologous stem cell transplant can provide significant remission that is both long and deep extending survival. There can be a long period of dormancy that could last.

It isn t a cure but compared to chemotherapy alone a. Multiple myeloma isn t considered curable but symptoms wax and wane. A stem cell transplant replaces diseased stem cells with healthy ones and is often used to treat this form of cancer. Long term survival in mm patients treated with asct has improved with the introduction of novel therapeutics.

The standard of care for fit multiple myeloma patients is to receive high dose chemotherapy hdt with autologous stem cell rescue otherwise known as autologous stem cell transplant asct after completion of induction therapy. In a stem cell transplant the patient gets high dose chemotherapy to kill the cells in the bone marrow. Multiple myeloma survival rate after stem cell transplant. Stem cell transplant for multiple myeloma.

In some cases a bone marrow or stem cell transplant is an option. A person with multiple myeloma is likely to have a low blood count. Then the patient receives new healthy blood forming stem cells. The transplant of this kind is the standard treatment for patients with various myeloma.

It can be a strong weapon in your fight against multiple myeloma.